Hussain M, Fizazi K, Saad F, et al. Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer. N Engl J Med. 2018, 378(26):2465-2474. doi: 10.1056/NEJMoa1800536.
Advertisement
Articles by Hussain M, Fizazi K, Saad F, et al. Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer. N Engl J Med. 2018, 378(26):2465-2474. doi: 10.1056/NEJMoa1800536.
Advertisement
Latest Updated Articles
- Study Summary: Use of Enzalutamide for High-Risk, Nonmetastatic, Castration-Resistant Prostate Cancer (PROSPER)
Published: November 9th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Congress Unveils Massive Funding Bill to Avert Shutdown
2
Gates Foundation, OpenAI Launch $50M AI Health Initiative in Africa
3
By Improving Sleep, TNX-102 SL Reduces Pain and Fatigue in Fibromyalgia
4
FDA Draft Guidance Proposes CR, MRD to Accelerate MM Drug Approval
5
